Smith & Nephew (SNN) Net Cash Flow Growth (1y) (2010 - 2024)
Smith & Nephew (SNN) Net Cash Flow Growth (1y) (2010 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.66 Bn | 175.36 Bn | 6.27 Bn | -53.07% |
| 2 | Stryker | 128.55 Bn | 125.68 Bn | 3.81 Bn | 17.60% |
| 3 | Medtronic | 108.38 Bn | 99.16 Bn | 6.41 Bn | 10.50% |
| 4 | Boston Scientific | 68.11 Bn | 66.66 Bn | 3.61 Bn | -283.58% |
| 5 | Edwards Lifesciences | 47.19 Bn | 43.52 Bn | 1.29 Bn | -564.44% |
| 6 | Dexcom | 28.54 Bn | 27.42 Bn | 750.30 Mn | -31.84% |
| 7 | GE HealthCare Technologies | 28.37 Bn | 26.09 Bn | 1.98 Bn | -394.13% |
| 8 | Smith & Nephew | 26.90 Bn | 26.33 Bn | - | - |
| 9 | Koninklijke Philips | 25.53 Bn | 22.40 Bn | 2.07 Bn | 76.43% |
| 10 | Steris | 21.52 Bn | 21.08 Bn | 697.10 Mn | 57.36% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 104.48% |
| Dec 31, 2023 | 72.43% |
| Dec 31, 2022 | -32.61% |
| Dec 31, 2021 | -73,200.00% |
| Dec 31, 2020 | 99.89% |
| Dec 31, 2019 | -641.71% |
| Dec 31, 2018 | 117.91% |
| Dec 31, 2017 | -6.54% |
| Dec 31, 2016 | 7.09% |
| Dec 31, 2015 | -312.97% |
| Mar 31, 2014 | -342.86% |
| Mar 31, 2013 | 94.75% |
| Dec 31, 2012 | 73.43% |
| Jun 30, 2012 | 931.31% |
| Mar 31, 2012 | -919.44% |
| Dec 31, 2011 | -193.86% |
| Sep 30, 2011 | 0.00% |
| Jun 30, 2011 | -280.77% |
| Mar 31, 2011 | -34.58% |
| Dec 31, 2010 | -143.51% |